Prenetics Global Ltd. is a health sciences company, which engages in providing consumer health products and services. The firm operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The firm's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The firm is also engaged in consumer health products by a new health and wellness brand IM8.
The current price of PRE is $17.89, it has increased 1.82% in the last trading day.
What are the primary business themes or industries for Prenetics Global Ltd?
Prenetics Global Ltd belongs to Health Care industry and the sector is Health Care
What is Prenetics Global Ltd market cap?
Prenetics Global Ltd's current market cap is $252.4M
Is Prenetics Global Ltd a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for Prenetics Global Ltd, including 1 strong buy, 4 buy, 1 hold, 0 sell, and 1 strong sell